BioSpace News Archive

WallStEquities.com is offering reports on MNK, MNTA, MYL, and NBIX which can be accessed for free by signing up to www.wallstequities.com/registration.

Acquisition expands endoscopic portfolio to include radiofrequency devices.

Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced that Stephen Hurly, president and chief executive officer, will present a company overview at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 12:00 p.m. ET in Boston.

The Parkinson’s Institute and Clinical Center and Denali Therapeutics Inc.s announced a partnership to explore new clinical endpoints for studies in patients with Parkinson’s Disease (PD).

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today its design for a randomized, double-blind, placebo-controlled Phase 3 clinical trial to evaluate GMI-1271 in combination with MEC (Mitoxantrone, etoposide and Ara-C) or in combination with FAI (fludarabine, cytosine arabinoside and idarubicin) in individuals with relapsed/refractory acute myeloid leukemia (AML).

Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument

Phase 2 ENCORE 601 PD-(L)1 refractory melanoma cohort data and melanoma registration strategy disclosure forthcoming in 2Q18; ENCORE 601 PD-(L)1 refractory NSCLC cohort data expected 2Q18; Initial data on MSS-CRC cohort of ENCORE 601 to drive decision on advancement into second stage expected in 2Q18; Company to host conference call today at 4:30 p.m. ET

CRH Medical Corporation announced its financial results for the quarter and full fiscal year ended December 31, 2017.

Sinovac Biotech Ltd. announced actions taken to enhance the corporate governance and management of Sinovac Biotech Co., Ltd., the main operating subsidiary of Sinovac.

Nobilis Health Corp. has announced that it will release its fourth quarter and full year 2017 financial results prior to market open on Thursday, March 8, 2018.